A

Arvinas
D

ARVN

10.560
USD
0.45
(4.45%)
مغلق
حجم التداول
51,817
الربح لكل سهم
-1
العائد الربحي
-
P/E
-13
حجم السوق
678,208,545
أصول ذات صلة الأخبار المقالات

العنوان: Arvinas

القطاع: Healthcare
الصناعة: Biotechnology
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.